| Winona Health Services Physician Group | |
|
855 Mankato Ave Winona MN 55987-4868 | |
| (507) 457-4321 | |
| (507) 474-3224 |
| Full Name | Winona Health Services Physician Group |
|---|---|
| Speciality | General Practice |
| Location | 855 Mankato Ave, Winona, Minnesota |
| Authorized Official Name and Position | Jan Brosnahan (CFO) |
| Authorized Official Contact | 5074543650 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Winona Health Services Physician Group 855 Mankato Ave Po Box 5600 Winona MN 55987-4868 Ph: (507) 457-4321 | Winona Health Services Physician Group 855 Mankato Ave Winona MN 55987-4868 Ph: (507) 457-4321 |
| NPI Number | 1720210099 |
|---|---|
| Provider Enumeration Date | 08/19/2009 |
| Last Update Date | 11/24/2021 |
| Medicare PECOS PAC ID | 8527977420 |
|---|---|
| Medicare Enrollment ID | O20100129000724 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720210099 | NPI | - | NPPES |
| 11004400 | Medicaid | WI | |
| 38040CO | Other | MN | BLUE SHIELD |
| 124847200 | Medicaid | MN | |
| 24D0041006 | Other | CLIA |
| Provider Name | Rajah S Sundaram |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1922002724 PECOS PAC ID: 1658349097 Enrollment ID: I20040922001161 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Andrew E Edin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1053428508 PECOS PAC ID: 6305925181 Enrollment ID: I20090303000433 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Frank A Bures |
|---|---|
| Provider Type | Practitioner - Dermatology |
| Provider Identifiers | NPI Number: 1992715577 PECOS PAC ID: 3779664396 Enrollment ID: I20090303000517 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Susan G Maclellan-tobert |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1952304834 PECOS PAC ID: 0941498984 Enrollment ID: I20101217000352 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Hjalti Gudmundsson |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1164632980 PECOS PAC ID: 1759415672 Enrollment ID: I20130816000402 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Carol K Powell |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1487634283 PECOS PAC ID: 7012815277 Enrollment ID: I20131220000535 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Christen Chamberland |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1194984716 PECOS PAC ID: 7416171624 Enrollment ID: I20140610000049 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Esosa G Odigie-okon |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1588815914 PECOS PAC ID: 0446573240 Enrollment ID: I20150603001080 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Christopher R Takala |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1013203652 PECOS PAC ID: 9032366638 Enrollment ID: I20160817001929 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
| Provider Name | Jennifer J Forsyth |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1225328735 PECOS PAC ID: 9830402320 Enrollment ID: I20230622001747 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc.
For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion - nearly $11,000 for each of the estimated 3.2 million people grappling with pain.
› Verified 3 days ago
Woolley Chiropractic Center Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3930 W 6th St, Winona, MN 55987 Phone: 507-452-4490 | |
Winona Clinic Ltd Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 859 Mankato Ave, Winona, MN 55987 Phone: 507-454-3680 Fax: 507-457-7672 | |
Winona Health Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 859 Mankato Ave, Winona, MN 55987 Phone: 507-454-3680 | |
Winona Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 859 Mankato Ave, Winona, MN 55987 Phone: 507-457-4521 Fax: 507-474-3284 | |
Family Medicine Of Winona P.a. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 825 Mankato Ave Ste 210, Winona, MN 55987 Phone: 507-454-5050 Fax: 507-454-5102 | |
Winona Health Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 855 Mankato Ave, Winona, MN 55987 Phone: 507-454-3650 Fax: 507-457-4413 | |
Winona Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 859 Mankato Ave, Winona, MN 55987 Phone: 507-457-4570 Fax: 507-474-3284 |